Mary Strange
Magee-Womens Research Institute
ORCID: 0000-0003-3269-4185Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity”.
Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more
Mary Strange, Yusi Fang, Ibrahim Uygun, Lixin Zhang, George C. Tseng +4 more
Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more
Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more
Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange, Syed I. A. Zaidi +12 more